Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Haiying Yu

Diagnostic Radiology Lansing, MI Medical Doctor

NPI 1396188595 CMS profile 5700589

1215 E Michigan Ave Fl 4, Lansing, MI 48912

Open in the dashboard

General payments

$14,110

92 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Haiying Yu of Lansing, MI is reported in the CMS Open Payments database as having received $14,110 across 92 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $274 14
2024 General $395 9
2023 General $9,414 16
2022 General $1,987 23
2021 General $492 15
2020 General $1,262 11
2019 General $285 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Haiying Yu
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Haiying Yu were reported at $274. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Haiying Yu Diagnostic Radiology median Middle half National median
2019 $285 $108 $29–$318 $163
2020 $1,262 $65 $21–$252 $114
2021 $492 $92 $24–$292 $132
2022 $1,987 $104 $29–$294 $149
2023 $9,414 $110 $29–$337 $160
2024 $395 $113 $30–$356 $164
2025 $274 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sirtex Medical Inc $11,797 23 payments
  2. Boston Scientific Corporation $518 12 payments
  3. Penumbra, Inc. $468 9 payments
  4. Inari Medical, Inc. $348 10 payments
  5. Bard Peripheral Vascular, Inc. $298 14 payments
  6. AngioDynamics, Inc. $97 4 payments
  7. Biocompatibles, Inc. $93 1 payment
  8. Siemens Medical Solutions USA, Inc. $81 2 payments
  9. Cardiva Medical, Inc. $73 3 payments
  10. Terumo Medical Corporation $65 3 payments
  11. Other $273 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,500 5 payments
  2. Food and Beverage $2,618 82 payments
  3. Travel and Lodging $984 4 payments
  4. Consulting Fee $7 1 payment
Products named General payments · program years 2019–2025
  1. SIR-Spheres Microspheres $11,782 22 payments
  2. FLOWTRIEVER CATHETER, S $418 11 payments
  3. CT THROMBECTOMY SYSTEM KIT $251 7 payments
  4. Indigo System $242 3 payments
  5. EMBOLD Fibered $155 2 payments
  6. GENERAL - EMBOLICS $149 2 payments
  7. Penumbra Ruby Coil $128 1 payment
  8. POD $97 5 payments
  9. THERASPHERE-BIO $93 1 payment
  10. Cardiva VASCADE MVP VVCS 6-12F $73 3 payments
  11. Other $768 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

83

Median for Interventional Radiology: 38

Drug cost

$260

Median for Interventional Radiology: $333

Branded share of claims

0%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cephalexin Generic 60 $126
Clindamycin Hcl Generic 12 $85
Methylprednisolone Generic 11 $49

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 79 billing codes

Paid by Medicare

$37,780

Medicare's payments for the services billed

Medicare patients

202

Average age 71

Services billed

588

99 women, 103 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Chronic kidney disease 48%
Depression 45%
Diabetes 43%
Ischemic heart disease 39%
Heart failure 37%
Atrial fibrillation 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

92 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record